Corneal Neovascularisation clinical trials

Explore recruiting corneal neovascularisation clinical trials.

Recruiting corneal neovascularisation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Corneal Neovascularisation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Antisense Oligonucleotide Eye Drops Against IRS-1 to Treat Pathological Corneal Neovascularisation in Aniridia-Associated Keratopathy (Olisens-Aniridia)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Antisense Oligonucleotide Eye Drops against IRS-1 to Optimize Pretransplant Lymphangio-regression Prior to High-Risk Keratoplasty (Olisens-Precon)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Corneal Neovascularisation trials by city

Corneal Neovascularisation in Toronto Corneal Neovascularisation in Vancouver Corneal Neovascularisation in Montreal Corneal Neovascularisation in Calgary Corneal Neovascularisation in Edmonton Corneal Neovascularisation in Ottawa Corneal Neovascularisation in Winnipeg Corneal Neovascularisation in Quebec City Corneal Neovascularisation in Hamilton Corneal Neovascularisation in Kitchener Corneal Neovascularisation in London Corneal Neovascularisation in Halifax Corneal Neovascularisation in New York Corneal Neovascularisation in Los Angeles Corneal Neovascularisation in Chicago Corneal Neovascularisation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease